CA2242579A1 - Benzimidzolyl neuropeptide y receptor antagonists - Google Patents
Benzimidzolyl neuropeptide y receptor antagonists Download PDFInfo
- Publication number
- CA2242579A1 CA2242579A1 CA002242579A CA2242579A CA2242579A1 CA 2242579 A1 CA2242579 A1 CA 2242579A1 CA 002242579 A CA002242579 A CA 002242579A CA 2242579 A CA2242579 A CA 2242579A CA 2242579 A1 CA2242579 A1 CA 2242579A1
- Authority
- CA
- Canada
- Prior art keywords
- alkylenyl
- alkoxy
- heterocyclic
- phenyl
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9600344.7A GB9600344D0 (en) | 1996-01-09 | 1996-01-09 | Benzimidzolyl neuropeptide y receptor antagonists |
GB9600344.7 | 1996-01-09 | ||
US2163696P | 1996-07-12 | 1996-07-12 | |
US60/021,636 | 1996-07-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2242579A1 true CA2242579A1 (en) | 1997-07-17 |
Family
ID=26308442
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002242579A Abandoned CA2242579A1 (en) | 1996-01-09 | 1997-01-09 | Benzimidzolyl neuropeptide y receptor antagonists |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0871442A1 (ja) |
JP (1) | JP2000501107A (ja) |
AU (1) | AU2242197A (ja) |
CA (1) | CA2242579A1 (ja) |
WO (1) | WO1997025041A1 (ja) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998040356A1 (fr) * | 1997-03-12 | 1998-09-17 | Banyu Pharmaceutical Co., Ltd. | Medicaments contenant des derives d'aminopyridine comme ingredient actif |
JP3711238B2 (ja) | 1997-08-05 | 2005-11-02 | ファイザー・プロダクツ・インク | 神経ペプチドY受容体アンタゴニストとしての4−アミノピロ−ル(3,2−d)ピリミジン |
SE9703414D0 (sv) * | 1997-09-23 | 1997-09-23 | Astra Ab | New compounds |
DE19801648A1 (de) * | 1998-01-17 | 1999-07-22 | Bayer Ag | alpha-Substituierte Lactone |
US6187777B1 (en) | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
WO2002046168A1 (en) * | 2000-12-07 | 2002-06-13 | Astrazeneca Ab | Therapeutic benzimidazole compounds |
TW593278B (en) * | 2001-01-23 | 2004-06-21 | Wyeth Corp | 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
BR0311593A (pt) | 2002-06-05 | 2005-04-26 | Hoffmann La Roche | Derivados de 1-sulfonil-4-aminoalcoxi indol como moduladores de receptor 5-ht6 para tratamento dos distúrbios de snc |
ZA200508439B (en) | 2003-05-05 | 2007-03-28 | Probiodrug Ag | Medical use of inhibitors of glutaminyl and glutamate cyclases |
ZA200603165B (en) | 2003-11-03 | 2007-07-25 | Probiodrug Ag | Combinations useful for the treatment of neuronal disorders |
EP1713780B1 (en) | 2004-02-05 | 2012-01-18 | Probiodrug AG | Novel inhibitors of glutaminyl cyclase |
JPWO2005080348A1 (ja) * | 2004-02-19 | 2007-08-02 | 萬有製薬株式会社 | 新規スルホンアミド誘導体 |
US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
WO2008055945A1 (en) | 2006-11-09 | 2008-05-15 | Probiodrug Ag | 3-hydr0xy-1,5-dihydr0-pyrr0l-2-one derivatives as inhibitors of glutaminyl cyclase for the treatment of ulcer, cancer and other diseases |
US9126987B2 (en) | 2006-11-30 | 2015-09-08 | Probiodrug Ag | Inhibitors of glutaminyl cyclase |
CN101668525A (zh) | 2007-03-01 | 2010-03-10 | 前体生物药物股份公司 | 谷氨酰胺酰环化酶抑制剂的新用途 |
EP2142514B1 (en) | 2007-04-18 | 2014-12-24 | Probiodrug AG | Thiourea derivatives as glutaminyl cyclase inhibitors |
KR101660059B1 (ko) | 2008-08-22 | 2016-09-26 | 박스알타 인코퍼레이티드 | 중합체 벤질 카르보네이트-유도체 |
SG178953A1 (en) | 2009-09-11 | 2012-04-27 | Probiodrug Ag | Heterocylcic derivatives as inhibitors of glutaminyl cyclase |
ES2586231T3 (es) | 2010-03-03 | 2016-10-13 | Probiodrug Ag | Inhibidores de glutaminil ciclasa |
DK2545047T3 (da) | 2010-03-10 | 2014-07-28 | Probiodrug Ag | Heterocycliske inhibitorer af glutaminylcyclase (QC, EC 2.3.2.5) |
WO2011131748A2 (en) | 2010-04-21 | 2011-10-27 | Probiodrug Ag | Novel inhibitors |
NZ608069A (en) | 2010-10-06 | 2014-06-27 | Glaxosmithkline Llc | Benzimidazole derivatives as pi3 kinase inhibitors |
ES2570167T3 (es) | 2011-03-16 | 2016-05-17 | Probiodrug Ag | Derivados de benzimidazol como inhibidores de glutaminil ciclasa |
CA2831710A1 (en) | 2011-03-31 | 2012-10-04 | Bayer Intellectual Property Gmbh | Substituted benzimidazoles as mps-1 kinase inhibitors |
CN103965113A (zh) * | 2014-05-06 | 2014-08-06 | 四川大学 | 1-羟乙基-2-取代苯氧甲基苯并咪唑类化合物及其制备方法 |
PL3461819T3 (pl) | 2017-09-29 | 2020-11-30 | Probiodrug Ag | Inhibitory cyklazy glutaminylowej |
JP6400869B1 (ja) * | 2018-02-23 | 2018-10-03 | 日本曹達株式会社 | 4,5−ジシアノ−2−(フルオロアルキル)イミダゾールの製造方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772703A (en) * | 1986-01-27 | 1988-09-20 | American Home Products Corporation | 2-(phenoxymethyl)-quinazolines as antiallergic and antiinflammatory agents |
-
1997
- 1997-01-09 JP JP9525457A patent/JP2000501107A/ja active Pending
- 1997-01-09 EP EP97905573A patent/EP0871442A1/en not_active Withdrawn
- 1997-01-09 AU AU22421/97A patent/AU2242197A/en not_active Abandoned
- 1997-01-09 WO PCT/US1997/000511 patent/WO1997025041A1/en not_active Application Discontinuation
- 1997-01-09 CA CA002242579A patent/CA2242579A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1997025041A1 (en) | 1997-07-17 |
JP2000501107A (ja) | 2000-02-02 |
AU2242197A (en) | 1997-08-01 |
EP0871442A1 (en) | 1998-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2242579A1 (en) | Benzimidzolyl neuropeptide y receptor antagonists | |
US5574044A (en) | Muscarine antagonists | |
US6340681B1 (en) | 2-benzimidazolylamine compounds as ORL-1-receptor agonists | |
US6025372A (en) | Somatostatin agonists | |
US6642228B1 (en) | α1b-adrenergic receptor antagonists | |
AU717422B2 (en) | Indolyl neuropeptide Y receptor antagonists | |
JP2000512296A (ja) | セロトニン再取込み阻害 | |
DE60119939T2 (de) | Chinolinderivate als antibakterielle mittel | |
JP3315970B2 (ja) | ニューロキニンアンタゴニストとしてのピペラジノ誘導体 | |
JP4870163B2 (ja) | Mch受容体アンタゴニストとしてのインダン誘導体 | |
US20030191164A1 (en) | Propane-1,3-dione derivatives | |
US7202245B2 (en) | Substituted 4-amino[1,2,4]triazolo[4,3-a] quinoxalines | |
SK404491A3 (en) | Tricyclic lactam compounds, pharmaceutical compositions comprising same and their use | |
CA3215564A1 (en) | Methods and compounds for restoring mutant p53 function | |
US5691323A (en) | Muscarine antagonists | |
CZ289479B6 (cs) | Pouľití piperidinových derivátů pro výrobu farmaceutických prostředků, piperidinové deriváty a farmaceutický prostředek | |
AU2006275568A1 (en) | Dipiperazinyl ketones and related analogues | |
WO2001027104A1 (fr) | Derives d'imidazolidinone a substitution | |
JP2004504303A (ja) | 選択的メラニン凝集ホルモン−1(mch1)受容体アンタゴニストおよびその使用 | |
EP1373220B1 (en) | Benzimidazoles that are useful in treating sexual dysfunction | |
US6960589B2 (en) | Benzimidazoles that are useful in treating sexual dysfunction | |
US6255494B1 (en) | Benzimidzolyl neuropeptide Y receptor antagonists | |
US20040127504A1 (en) | Benzimidazoles that are useful in treating sexual dysfunction | |
US7351828B2 (en) | Benzimidazoles that are useful in treating sexual dysfunction | |
US6506756B2 (en) | Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |